News from vermillion, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 24, 2014, 09:15 ET

Vermillion Announces Closing of Equity Financing

 Vermillion, Inc. (Nasdaq:  VRML), a bio-analytical solutions company focused on gynecologic disease, announced today that the Company...

Dec 23, 2014, 09:15 ET

Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program

Vermillion, Inc. (Nasdaq:  VRML), a bio-analytical solutions company focused on gynecologic disease, announced today that investors including...

Dec 16, 2014, 16:05 ET

Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board

 Vermillion, Inc. (NASDAQ: VRML), a bio-analytic solutions company focused on gynecologic disease, today announced the next step in its...

Dec 12, 2014, 09:00 ET

Vermillion Strengthens Board of Directors with Appointments of Veronica Jordan, Ph.D., and David Schreiber

 Vermillion, Inc. (NasdaqCM: VRML), a bio-analytical solutions company focused on gynecologic disease, announced today the appointments of...

Nov 18, 2014, 17:45 ET

Vermillion Outlines Expanded Strategic Mission; Forms New Strategic & Medical Advisory Board

Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, recently outlined its expanded strategy for...

Nov 13, 2014, 16:01 ET

Vermillion Reports Third Quarter 2014 Results and Announces Expanded Strategy

Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, reported on its results for the quarter ended...

Oct 30, 2014, 16:01 ET

Vermillion Sets Third Quarter 2014 Conference Call for Thursday, November 13, 2014

Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, will hold a conference call...

Oct 27, 2014, 17:10 ET

Vermillion Appoints Valerie Palmieri as Chief Operating Officer

 Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, has appointed Valerie...

Aug 21, 2014, 16:01 ET

Vermillion Appoints Holly B. Bauzon as VP of Sales and Managed Markets

 Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, has appointed Holly B....

Aug 14, 2014, 16:01 ET

Vermillion Reports Second Quarter 2014 Results

Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, reported on its results for...

Aug 14, 2014, 09:15 ET

Vermillion Announces Additions to Commercial Management Team

 Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, has appointed David...

Jul 31, 2014, 09:15 ET

Vermillion Sets Second Quarter 2014 Conference Call for Thursday, August 14, 2014

Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, will hold a conference call...

Jul 28, 2014, 11:00 ET

Vermillion to Present on ASPiRA LABS, a New Women's Health Laboratory Specializing in OVA1, at AACC

 Medical experts representing Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and...

Jun 17, 2014, 16:01 ET

Vermillion Appoints Dr. Judith K. Wolf as Chief Medical Officer

AUSTIN, Texas, June 17, 2014 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic...

May 15, 2014, 16:01 ET

Vermillion Reports First Quarter 2014 Results

Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, reported on its results for...

May 08, 2014, 17:06 ET
Vermillion supports World Ovarian Cancer Day: You can save a life (PRNewsFoto/Vermillion, Inc.)

Moffitt Cancer Center and Vermillion Collaborate to Model Improvements in Ovarian Cancer Care Quality, Patient Outcomes and Cost

A new research collaboration anchored by Moffitt Cancer Center in Tampa, Fla., was announced today in conjunction with World Ovarian Cancer Day....

May 01, 2014, 08:31 ET

Vermillion Sets First Quarter 2014 Conference Call for Thursday, May 15, 2014

Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, will hold a conference call...

Apr 28, 2014, 07:00 ET

Vermillion Launches ASPiRA LABS

 Vermillion today launched ASPiRA LABS, which will specialize in applying the latest biomarker-based technologies to address critical needs in...

Apr 23, 2014, 16:05 ET

Vermillion Appoints Chairman of Board James LaFrance as President and Chief Executive Officer

 Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, has appointed James...

Mar 20, 2014, 09:50 ET

American Journal of Obstetrics & Gynecology Publishes New Clinical Study on the Relationship Between Imaging and OVA1® in Assessing Risk of Ovarian Cancer

(Nasdaq: VRML) -- A new study of OVA1® clinical performance, titled "The Effect of Ovarian Imaging on the Clinical...